Key result
Polymorphisms in the adiponectin gene were not associated with type 2 diabetes or BMI, but the rs182052 G allele was associated with a lower frequency of myocardial infarction.
Why the study?
Do polymorphisms in the adiponectin gene locus associate with Type 2 diabetes, BMI, or cardiovascular traits in the Latvian population?
Observational (n=835)
Do polymorphisms in the adiponectin gene locus associate with Type 2 diabetes, BMI, or cardiovascular traits in the Latvian population?
SNPs in the adiponectin gene are unlikely to represent a major risk for T2D or BMI changes but may be involved in the pathogenesis of coronary heart disease in the Latvian population.
Answers are grounded in this paper and cite their sources.
Should not guide genetic risk assessment for type 2 diabetes or BMI; leaves open possible MI protection by rs182052 G allele needing replication.
Analysis of Polymorphisms at the Adiponectin Gene Locus in Association with Type 2 Diabetes, Body Mass Index and Cardiovascular Traits in Latvian Population Despite the number of recently conducted studies seeking to determine the association between genetic variants of adiponectin gene and susceptibility to type 2 diabetes (T2D) and increased body mass index (BMI), the results obtained are often inconsistent. To determine the impact of common polymorphisms in promoter and coding regions of adiponectin gene on these conditions in Latvian population, we selected ten SNPs (rs2241767, rs1501299, rs3777261, rs16861210, rs2241766, rs822396, rs182052, rs17300539, rs16861194, rs266729) based on haploblock structure and previously reported association studies. The selected SNPs were screened in a study group of 835 participants from the Genome Data Base of Latvian Population and mainly consisted of patients with T2D and coronary heart disease. None of the individual polymorphisms were significantly associated with T2D status or BMI when analysed using logistic or linear regression and adjusted for gender, age and other significant covariates. Frequency of rs2241766 T allele homozygotes however was significantly increased in T2D patients compared to controls (uncorrected P = 0.007). When analysed with other traits, the rs182052 G allele was found to be less frequent in patients suffering from myocardial infarction (P = 0.02; OR = 0.76, CI95% [0.61-0.92]) compared to others. Haplotype analysis revealed significant association of one haplotype with atrial fibrillation (uncorrected P = 0.01). In summary, we conclude that SNPs in adiponectin gene are unlikely to represent the risk for T2D, but may be involved in pathogenesis of CHD in the Latvian population.
No takes yet. Share an insight, caveat, or question.
Kalniņa et al. (2009) conducted an observational in Type 2 Diabetes, Body Mass Index, and Cardiovascular Traits (n=835). ADIPOQ gene polymorphisms vs. Reference genotypes was evaluated on Myocardial infarction (OR 0.76, 95% CI 0.61-0.92, p=0.02). Polymorphisms in the adiponectin gene were not associated with type 2 diabetes or BMI, but the rs182052 G allele was associated with a lower frequency of myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: